Zharikov Yu O, Kovalenko Yu A, Olifir A A, Kalinin D V, Czhao A V
A.V. Vishnevsky Institute of Surgery, Moscow, Russia.
Khirurgiia (Mosk). 2017(1):27-31. doi: 10.17116/hirurgia2017127-31.
The objective of this study was to derive a prognostic scale to predict overall survival (OS) after a curative resection of perihilar cholangiocarcinoma (PHC).
The data of 55 patients with portal cholangiocarcinoma were analysed. Patients were treated at the A.V. Vishnevsky Institute of Surgery from 2011 to 2015. Surgical treatment after biliary decompression was performed in 37 (67.3%) patients. In the long-term period we observed 36 (97.3%) of the operated patients. The dependence of the OS of clinical and pathological factors of the tumor was analysed using mono- and multifactor regression analysis of Cox proportional hazards models for all operated patients.
Total 1-3-, 5-year survival rate was 75.1, 60.5, 37.7, 35% respectively. Significant prognostic factors (monofactorial analysis) include perineural (p=0,05) and vascular invasion (p=0,049), R1 resection (p=0,01), disease stage III or higher (p=0,03), invasion of SI liver (p=0,004), tumor cells differentiation degree (grade) 2 and higher (p=0,0006). Multifactor analysis revealed that the low OS have determined by perineural (p=0,05) and vascular invasion (p=0,008), the degree of differentiation of tumor cells (p=0,001), disease stage (p=0,05), surgical resection margin (p=0.0345). Developed method of predicting OS is a score of prognostic factors.
The scale of individual prognosis in patients PHC takes into account both clinical and histopathological tumor characteristics. This scale may be useful to optimize the individual treatment.
本研究的目的是推导一种预后量表,以预测肝门部胆管癌(PHC)根治性切除术后的总生存期(OS)。
分析了55例肝门部胆管癌患者的数据。这些患者于2011年至2015年在A.V. 维什涅夫斯基外科研究所接受治疗。37例(67.3%)患者在胆道减压后接受了手术治疗。在长期随访中,我们观察了36例(97.3%)接受手术的患者。使用Cox比例风险模型对所有接受手术的患者进行单因素和多因素回归分析,以分析肿瘤的临床和病理因素对总生存期的影响。
1年、3年、5年总生存率分别为75.1%、60.5%、37.7%、35%。显著的预后因素(单因素分析)包括神经周围侵犯(p = 0.05)、血管侵犯(p = 0.049)、R1切除(p = 0.01)、疾病分期III期或更高(p = 0.03)、侵犯肝S1段(p = 0.004)、肿瘤细胞分化程度2级及更高(p = 0.0006)。多因素分析显示,总生存期低由神经周围侵犯(p = 0.05)、血管侵犯(p = 0.008)、肿瘤细胞分化程度(p = 0.001)、疾病分期(p = 0.05)、手术切缘(p = 0.0345)决定。所开发的预测总生存期的方法是一个预后因素评分。
PHC患者的个体预后量表考虑了肿瘤的临床和组织病理学特征。该量表可能有助于优化个体化治疗。